Enhanced Zinc Lozenges

Item #01961 30 Vegetarian Lozenges 1 per serving In Stock
Free Shipping

on orders over € 40 to Pickup location

Money Back Guarantee

We have a 100 days return policy, not the standard 30 days!

Daily Shipping

Order before 14:00 CET, for same day shipping (Mon-Fri)

Customer Care Advisory

Note we also have call numbers in 6 countries

Enhanced Zinc Lozenges

Item #01961 30 Vegetarian Lozenges 1 per serving In Stock
€12.13 Sale €12.13 Save

Available, delivery time 3-4 weeks

Buy 4 get 10 % discount
Buy 1
Buy 2
5 % discount
Buy 4
10 % discount
Supplement Facts
Supplement Facts

Serving Size 1 vegetarian lozenge

Servings Per Container 30

Amount Per Serving

Calories

20

Total Carbohydrate

5 g

Sugars

4 g

Zinc (as zinc acetate)

18.75 mg

Other ingredients: dextrose, peppermint flavor, stearic acid, vegetable stearate, silica.

Dosage and Use
  • Completely dissolve in mouth one (1) lozenge every 2 wakeful hours, not to exceed 8 lozenges per day, or as recommended by a healthcare practitioner.
  • Do not use for more than 3 consecutive days.
  • Do not chew or swallow lozenge.
  • May cause nausea if taken on empty stomach.
Caution

Supplemental zinc can inhibit the absorption and availability of copper. If more than 50 mg of supplemental zinc is taken daily on a chronic basis, 2 mg of supplemental copper should also be taken to prevent copper deficiency. Chronic ingestion of more than 100 mg of zinc daily may be immunosuppressive for some aspects of T-cell and NK cell function.

Warnings
KEEP OUT OF REACH OF CHILDREN.
DO NOT EXCEED RECOMMENDED DOSE.
Do not purchase if outer seal is broken or damaged.
If you are undergoing treatment for a medical condition or if you are pregnant or lactating, please consult with your medical practitioner first.
 
A food supplement should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Store tightly closed in a cool and dry place.

  1. Curr Ther Res. 1998;59:595–607.
  2. Ann Intern Med. 2000;133:245-52.
  3. J Infect Dis. 2008;197:795-802.
  4. Grungreiff K, Reinhold D. Liver cirrhosis and “liver” diabetes mellitus are linked by zinc deficiency. Med Hypotheses. 2005;64(2):316-7.
  5. Prasad AS. Zinc: the biology and therapeutics of an ion. Ann Intern Med. 1996 Jul 15;125(2):142-4.
  6. Kasperczyk S, Birkner E, Kasperczyk A, Zalejska-Fiolka J. Activity of superoxide dismutase and catalase in people protractedly exposed to lead compounds. Ann Agric Environ Med. 2004;11(2):291-6.
  7. Kocaturk PA, Kavas GO, Erdeve O, Siklar Z. Superoxide dismutase activity and zinc and copper concentrations in growth retardation. Biol Trace Elem Res. 2004;102(1-3):51-9.
  8. Landis GN, Tower J. Superoxide dismutase evolution and life span regulation. Mech Ageing Dev. 2005 Mar;126(3):365-79.
  9. Noor R, Mittal S, Iqbal J. Superoxide dismutase—applications and relevance to human diseases. Med Sci Monit. 2002 Sep;8(9):RA210-5.
  10. Kato S, Saeki Y, Aoki M, et al. Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models. Acta Neuropathol (Berl). 2004 Feb;107(2):149-58.
  11. Raqib R, Roy SK, Rahman MJ, et al. Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis. Am J Clin Nutr. 2004 Mar;79(3):444-50.
  12. Bogden JD. Influence of zinc on immunity in the elderly. J Nutr Health Aging. 2004;8(1):48-54.
  13. Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukoc Biol. 2002 Jan;71(1):16-32.
  14. Chandra RK. Impact of nutritional status and nutrient supplements on immune responses and incidence of infection in older individuals. Ageing Res Rev. 2004 Jan;3(1):91-104.
  15. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004;24:277-98.
  16. Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996 Jul 15;125(2):81-8.
  17. Hulisz D. Efficacy of zinc against common cold viruses: an overview. J Am Pharm Assoc (Wash.DC.). 2004 Sep;44(5):594-603.
  18. Anzueto A, Niederman MS. Diagnosis and treatment of rhinovirus respiratory infections. Chest. 2003 May;123(5):1664-72.
  19. Eby GA. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Biosci Rep. 2004 Feb;24(1):23-39.
  20. McElroy BH, Miller SP. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects. Am J Ther. 2003 Sep;10(5):324-9.
  21. McElroy BH, Miller SP. Effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) against the common cold in school-aged subjects: a retrospective chart review. Am J Ther. 2002 Nov;9(6):472-5.
  22. Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000 Aug 15;133(4):245-52.